80
Views
6
CrossRef citations to date
0
Altmetric
Expert Opinion

Armodafinil in the treatment of sleep/wake disorders

, &
Pages 417-427 | Published online: 16 Jul 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Junyi Yang & Junfa Gao. (2019) Solriamfetol for the treatment of excessive daytime sleepiness associated with narcolepsy. Expert Review of Clinical Pharmacology 12:8, pages 723-728.
Read now

Articles from other publishers (5)

Nasser M. Alorfi. (2022) Pharmacological treatments of fibromyalgia in adults; overview of phase IV clinical trials. Frontiers in Pharmacology 13.
Crossref
Michael J. Thorpy & Richard K. Bogan. (2020) Update on the pharmacologic management of narcolepsy: mechanisms of action and clinical implications. Sleep Medicine 68, pages 97-109.
Crossref
Sheila N. Garland, Joseph A. Roscoe, Charles E. Heckler, Holly Barilla, Philip Gehrman, James C. Findley, Anita R. Peoples, Gary R. Morrow, Charles Kamen & Michael L. Perlis. (2016) Effects of armodafinil and cognitive behavior therapy for insomnia on sleep continuity and daytime sleepiness in cancer survivors. Sleep Medicine 20, pages 18-24.
Crossref
S.C. Veasey. 2013. Encyclopedia of Sleep. Encyclopedia of Sleep 532 536 .
John M. Kane, Ronghua Yang & James M. Youakim. (2012) Adjunctive armodafinil for negative symptoms in adults with schizophrenia: A double-blind, placebo-controlled study. Schizophrenia Research 135:1-3, pages 116-122.
Crossref